News Release(2014)

December 12, 2014

Announcement of the Launch of "SALAGEN® Granules 0.5%" for the Treatment of Dry Mouth Symptoms

November 19, 2014

New Drug Application Submitted for "PA21 (development code)" for Treatment of Hyperphosphatemia

May 20, 2014

Kissei Pharmaceutical Co., Ltd. submits a public knowledge-based application for a respiratory stimulant DOPRAM® injectable 400mg for the additional indication of an apneic attack of prematurity

May 14, 2014

Announcement of the death of our company's Honorary Chairman, Kunio Kanzawa (former Chairman)

April 25, 2014

Announcement on change of President

April 17, 2014

Announcement of the launch of "SAVENE® Injectable 500mg" for the Treatment of Anthracycline Extravasation in Japan

February 13, 2014

Kissei Announces Business Collaboration Agreement with Alteogen

January 17, 2014

New Drug Application Approval for "SAVENE® Injectable 500mg" for the Treatment of Anthracycline Extravasation in Japan